Filing Details BIO KEY INTERNATIONAL INC (NASDAQ:BKYI) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 24, 2026. The Industrials…
BIO KEY INTERNATIONAL INC (NASDAQ:BKYI) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on July 24, 2026.
The Industrials company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
BIO KEY INTERNATIONAL INC's stock currently trades at $4.55 with a market capitalization of $4.7M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing BIO KEY INTERNATIONAL INC's filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for BIO KEY INTERNATIONAL INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BKYI Stock Page
Browse all filings on our BKYI SEC filings page.
Public companies like BIO KEY INTERNATIONAL INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · BKYI
$2.81
Down: -$0.03 · -1.07%
Live quote updated
Keep reading
